Next-generation Mobility Shift Assay Detection System!

We have great News for you: MSA is still accessible to your drug discovery research!

Kudos to the profiling team at Carna Biosciences, Inc. for their exceptional work in developing the next-generation Mobility Shift Assay Detection System. It's fantastic to see that the MSA is still accessible to our drug discovery clients.

Carna‘s novel, next-gen Mobility Shift Assay Detection system has been established using the BioPhase™ 8800 Capillary Electrophoresis System from Sciex with integration of an originally programmed robotic arm to accelerate the instrument’s throughput.

This unique and powerful system, in house at Carna, enables us to continue to support your kinase inhibitor research whenever you contract our Services! Using the same kinase reaction conditions, we provide the same high-quality data and consistent with 20 years of historical data produced using the previous detection system.

View how the new system works and see the consistency between new and historical data in a newly released video.

Are you interested in learning more about the new system or have a project that could benefit from this service? Please contact us

Carna Biosciences remains your trusted partner for Mobility Shift Assay services in kinase drug discovery!

Further news

  • Biotinylated Kinases General

    Biotinylated Kinases

    We’ve new products for you: biologically biotinylated human Kinases from Carna Biosciences.

    Read more
  • New Cellular CDK Assay Panel Launched and Special Offers from Carna Offers

    New Cellular CDK Assay Panel Launched and Special Offers from Carna

    We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.

    Read more
  • New Website Launch! General

    New Website Launch!

    We’re extremely pleased to announce the launch of our new website!

    We decided that it was time for a fresh new look, which surely empowers our…

    Read more
Contact us